According to experts, it’s too early to say that the credit should be given to Keytruda for the ex president’s apparently successful treatment, however, new cancer drugs, such as it, have been showing promising results so far.

Undoubtedly it has shown a lot of promise, but the latest immune therapy drug used for the treatment of former President Jimmy Carter’s cancer still has a long way ahead to get the status of a ‘miracle drug’.

While speaking to Healthline, many medical experts have said that it was quite early to tell how much credit should be given to the drug Keytruda for Carter’s successful treatment. The medication is among a new class of cancer-fighting drugs that have been planned to sic the body’s own immune system on cancers.

In the case of Carter, the drug has apparently shrunk the tumors in his brain, making it undetectable. Presently, Carter and his doctors are waiting to see whether the melanoma will make a comeback or not.

Keytruda could be beneficial for many, but not all of them will have access to it. This is because there are many insurance providers that don’t include the medication, whose estimated cost is $150,000 per year.

Carter made an announcement in August that the melanoma being cut out of his liver by doctors had materialized in 4 tiny sections in his brain. Carter then had to undergo 4 radiation treatments, targeting the cancer in his brain. He even began consumption of Keytruda.

In an announcement at his church on Sunday, Carter said that his recent tests showed his brain cancer free. Some people called his recovery a miracle, however, many medical experts told Healthline that the news was not at all surprised for them.